HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Behavioral changes induced by long-term proline exposure are reversed by antipsychotics in zebrafish.

Abstract
Hyperprolinemia is an inherited disorder of proline metabolism and patients affected by this disease may present neurological manifestations, including seizures and cognitive dysfunctions. Moreover, an association between adulthood schizoaffective disorders and moderate hyperprolinemia has been reported. However, the mechanisms underlying these behavioral phenotypes still remain unclear. In the present study, we investigated the effect of proline treatments on behavioral parameters in zebrafish, such as locomotor activity, anxiety, and social interaction. Adult zebrafish (Danio rerio) were exposed to proline (1.5 and 3.0 mM) during 1h or 7 days (short- or long-term treatments, respectively). Short-term proline exposure did not promote significant changes on the behavioral parameters observed. Long-term exposure at 1.5 mM proline significantly increased the number of line crossing (47%), the total distance (29%), and the mean speed (33%) when compared to control group. A significant increase in the time spent in the upper portion of the test tank was also observed after this treatment (91%), which may be interpreted as an indicator of anxiolytic behavior. Proline at 1.5 mM also induced social interaction impairment (78%), when compared to the untreated group after long-term treatment. Moreover, these proline-induced behavioral changes in zebrafish were completely reversed by acute administration of an atypical antipsychotic drug (sulpiride), but not by a typical (haloperidol). These findings demonstrate that proline is able to induce schizophrenia-like symptoms in zebrafish, which reinforce the use of this species as a complementary vertebrate model for studying behavioral phenotypes associated with neurological dysfunctions characteristic of metabolic diseases.
AuthorsLuiz Eduardo Baggio Savio, Fernanda Cenci Vuaden, Angelo L Piato, Carla Denise Bonan, Angela T S Wyse
JournalProgress in neuro-psychopharmacology & biological psychiatry (Prog Neuropsychopharmacol Biol Psychiatry) Vol. 36 Issue 2 Pg. 258-63 (Mar 30 2012) ISSN: 1878-4216 [Electronic] England
PMID22019856 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Antipsychotic Agents
  • Sulpiride
  • Proline
  • 1-Pyrroline-5-Carboxylate Dehydrogenase
  • Proline Oxidase
  • Haloperidol
Topics
  • 1-Pyrroline-5-Carboxylate Dehydrogenase (deficiency)
  • Amino Acid Metabolism, Inborn Errors (chemically induced, complications, drug therapy)
  • Animals
  • Antipsychotic Agents (pharmacology, therapeutic use)
  • Anxiety (complications, drug therapy)
  • Disease Models, Animal
  • Drug Interactions
  • Female
  • Haloperidol (pharmacology, therapeutic use)
  • Locomotion (drug effects)
  • Male
  • Proline (antagonists & inhibitors, pharmacology)
  • Proline Oxidase (deficiency)
  • Social Behavior
  • Sulpiride (pharmacology, therapeutic use)
  • Time Factors
  • Zebrafish

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: